James Loerop

James Loerop

Corporate Officer/Principal chez ACLARIS THERAPEUTICS, INC.

Fortune : 37 419 $ au 30/06/2024

60 ans
Health Technology
Consumer Services

Profil

James Loerop is currently the Chief Business Officer at Aclaris Therapeutics, Inc. He previously worked as the EVP-Business Development & Strategic Planning at Anika Therapeutics, Inc. from 2019 to 2022.
Prior to that, he was the SVP-Global Business Development at Alexion Pharmaceuticals, Inc. from 2015 to 2017.
From 2006 to 2010, he served as the SVP-Global Corporate Development at Stiefel Laboratories, Inc. Mr. Loerop also held the position of Chief Corporate Development Officer at Lupin Pharmaceuticals, Inc. from 2017 to 2019.
He started his career at GlaxoSmithKline LLC as the VP-North America Business Development from 2010 to 2015.
Mr. Loerop obtained his undergraduate degree from Western Michigan University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
16/04/2024 34 017 ( 0,05% ) 37 419 $ 30/06/2024

Postes actifs de James Loerop

SociétésPosteDébut
ACLARIS THERAPEUTICS, INC. Corporate Officer/Principal 31/01/2022
Tous les postes actifs de James Loerop

Anciens postes connus de James Loerop

SociétésPosteFin
ANIKA THERAPEUTICS, INC. Corporate Officer/Principal 01/01/2022
Corporate Officer/Principal 01/07/2019
ALEXION PHARMACEUTICALS, INC. Corporate Officer/Principal 01/09/2017
Corporate Officer/Principal 01/04/2015
Corporate Officer/Principal 01/12/2010
Voir l'expérience en détail de James Loerop

Formation de James Loerop

Western Michigan University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de James Loerop

Relations

100 +

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
ANIKA THERAPEUTICS, INC.

Health Technology

ACLARIS THERAPEUTICS, INC.

Health Technology

Entreprise privées4

Health Technology

Health Technology

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. James Loerop